$GRAL
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Healthcare
Sector
Medical - Diagnostics & Research
Industry
Robert Ragusa
CEO
1000
Employees
$117.81
Current Price
$3.77B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 8 | $7,347,058.59 | 51,492 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 19 | $13,736,116.10 | 117,044 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 3 | 21 | $14,832,793.10 | 129,944 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Ofman Joshua J. Director | Sale | 400 | $133.12 | $53,247.00 | View Details |
| Oct 15, 2026 | Ofman Joshua J. Director | Sale | 6,034 | $137.63 | $830,465.45 | View Details |
| Oct 15, 2026 | Ofman Joshua J. Director | Sale | 7,052 | $136.83 | $964,945.61 | View Details |
| Oct 15, 2026 | Ofman Joshua J. Director | Sale | 3,400 | $135.44 | $460,507.90 | View Details |
| Oct 15, 2026 | Ofman Joshua J. Director | Sale | 2,114 | $138.79 | $293,394.45 | View Details |
| Oct 15, 2026 | Ofman Joshua J. Director | Sale | 1,000 | $134.38 | $134,384.30 | View Details |
| Oct 5, 2026 | Partridge Andrew John Chief Growth Officer | Sale | 7,873 | $146.39 | $1,152,528.47 | View Details |
| Oct 5, 2026 | Freidin Aaron Chief Financial Officer | Sale | 23,619 | $146.39 | $3,457,585.41 | View Details |
| Sep 21, 2026 | Freidin Aaron Chief Financial Officer | Sale | 1,779 | $92.26 | $164,136.05 | View Details |
| Sep 21, 2026 | Freidin Aaron Chief Financial Officer | Sale | 1,800 | $93.92 | $169,048.08 | View Details |
| Sep 21, 2026 | Freidin Aaron Chief Financial Officer | Sale | 521 | $95.00 | $49,495.00 | View Details |
| Sep 21, 2026 | Ofman Joshua J. Director | Sale | 6,200 | $96.43 | $597,870.96 | View Details |
| Sep 21, 2026 | Ofman Joshua J. Director | Sale | 10,000 | $110.00 | $1,100,000.00 | View Details |
| Sep 21, 2026 | Ofman Joshua J. Director | Sale | 2,125 | $92.32 | $196,169.80 | View Details |
| Sep 21, 2026 | Ofman Joshua J. Director | Sale | 2,100 | $100.68 | $211,429.05 | View Details |
| Sep 21, 2026 | Ofman Joshua J. Director | Sale | 1,400 | $97.84 | $136,977.96 | View Details |
| Sep 21, 2026 | Ofman Joshua J. Director | Sale | 37,752 | $94.98 | $3,585,790.67 | View Details |
| Sep 21, 2026 | Ofman Joshua J. Director | Sale | 1,454 | $93.61 | $136,103.12 | View Details |
| Sep 21, 2026 | Ofman Joshua J. Director | Sale | 421 | $99.85 | $42,036.81 | View Details |
| Aug 27, 2026 | Ofman Joshua J. Director | Sale | 5,000 | $85.02 | $425,098.00 | View Details |
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$2.45
ActualN/A
Revenue
Estimated$44.21M
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.